CN114650810A - 多药物递送系统和方法 - Google Patents

多药物递送系统和方法 Download PDF

Info

Publication number
CN114650810A
CN114650810A CN202080074708.5A CN202080074708A CN114650810A CN 114650810 A CN114650810 A CN 114650810A CN 202080074708 A CN202080074708 A CN 202080074708A CN 114650810 A CN114650810 A CN 114650810A
Authority
CN
China
Prior art keywords
tablet
capsule
drug
estradiol
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080074708.5A
Other languages
English (en)
Chinese (zh)
Inventor
邱怡虹
D·周
M·舍普利
J·W-K·伍
A·默罕默德
J-H·韩
D·梅茨格尔
A·鲁格尔斯
祖卉
X·邵
龚豫川
Y·陈
J·龚
M·李
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
AbbVie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AbbVie Inc filed Critical AbbVie Inc
Publication of CN114650810A publication Critical patent/CN114650810A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202080074708.5A 2019-08-29 2020-08-27 多药物递送系统和方法 Pending CN114650810A (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962893567P 2019-08-29 2019-08-29
US201962893573P 2019-08-29 2019-08-29
US62/893573 2019-08-29
US62/893567 2019-08-29
US202062981180P 2020-02-25 2020-02-25
US62/981180 2020-02-25
US202063022823P 2020-05-11 2020-05-11
US63/022823 2020-05-11
PCT/US2020/048107 WO2021041608A1 (en) 2019-08-29 2020-08-27 System and method of multi-drug delivery

Publications (1)

Publication Number Publication Date
CN114650810A true CN114650810A (zh) 2022-06-21

Family

ID=74683538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080074708.5A Pending CN114650810A (zh) 2019-08-29 2020-08-27 多药物递送系统和方法

Country Status (9)

Country Link
EP (1) EP4021420A4 (es)
JP (1) JP2022546496A (es)
CN (1) CN114650810A (es)
AU (1) AU2020336093A1 (es)
BR (1) BR112022003895A2 (es)
CA (1) CA3152734A1 (es)
IL (1) IL290961A (es)
MX (1) MX2022002526A (es)
WO (1) WO2021041608A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113876728A (zh) * 2021-11-17 2022-01-04 南京唯创远医药科技有限公司 一种噁拉戈利冻干片及其制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022040896A1 (en) * 2020-08-25 2022-03-03 Abbvie Inc. System and method of multi-drug delivery
US11273128B1 (en) * 2021-04-15 2022-03-15 Sandoz Ag Elagolix formulation
JP7454692B2 (ja) * 2021-08-26 2024-03-22 寧徳時代新能源科技股▲分▼有限公司 液体カプセル、電池単体、電池および電力使用装置
EP4279075A1 (en) * 2022-05-12 2023-11-22 Zaklady Farmaceutyczne Polpharma S.A. A pharmaceutical composition comprising elagolix

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US20080075772A1 (en) * 2006-04-13 2008-03-27 Lawrence Solomon Pharmaceutical compositions having novel scoring patterns and methods of using those compositions
US20100255082A1 (en) * 2008-07-31 2010-10-07 Ishwar Chauhan Functionally Coated Breakable Tablets
KR101861307B1 (ko) * 2011-10-13 2018-07-06 한미약품 주식회사 정제를 포함하는 경질 캡슐 복합 제형
US10881659B2 (en) * 2013-03-15 2021-01-05 Abbvie Inc. Methods of treating heavy menstrual bleeding
US9456987B2 (en) * 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
US20190201285A1 (en) * 2016-08-23 2019-07-04 Mylan Inc. Child Resistant Medication Packaging
WO2019036713A1 (en) * 2017-08-18 2019-02-21 Abbvie Inc. SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113876728A (zh) * 2021-11-17 2022-01-04 南京唯创远医药科技有限公司 一种噁拉戈利冻干片及其制备方法
CN113876728B (zh) * 2021-11-17 2022-12-13 南京唯创远医药科技有限公司 一种噁拉戈利冻干片及其制备方法

Also Published As

Publication number Publication date
BR112022003895A2 (pt) 2022-05-24
MX2022002526A (es) 2022-06-23
EP4021420A4 (en) 2023-11-22
IL290961A (en) 2022-04-01
AU2020336093A1 (en) 2022-03-31
EP4021420A1 (en) 2022-07-06
JP2022546496A (ja) 2022-11-04
CA3152734A1 (en) 2021-03-04
WO2021041608A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
CN114650810A (zh) 多药物递送系统和方法
JP6259490B2 (ja) ベンダムスチンの経口投与形及びその治療的使用
JP5886632B2 (ja) オキシコドンおよびナロキソンを含む即時放出医薬組成物
US20180207100A1 (en) Solid dosage forms of palbociclib
KR102094631B1 (ko) 비만 및 관련 대사 장애의 치료를 위한 오를리스타트 및 아카르보스의 변형 방출형 조성물
JP7350715B2 (ja) 子宮内膜症、子宮筋腫、多嚢胞性卵巣症候群及び腺筋症を処置するための固形医薬製剤
KR101588259B1 (ko) 독실아민 및 피리독신 및/또는 이들의 대사물질들 또는 염들의 제형물
AU2001272243A1 (en) Rapid onset formulation
WO2003000263A1 (en) Rapid onset formulation
KR20090015890A (ko) 저 홍조 니아신 제형
Zhang et al. The development of minitablets for a pediatric dosage form for a combination therapy
KR20160030093A (ko) 구강 내 붕괴정
JP4866170B2 (ja) 睡眠薬の放出制御医薬組成物及びその製造方法
WO2022040896A1 (en) System and method of multi-drug delivery
WO2023047274A1 (en) Extended release pharmaceutical compositions of dydrogesterone
US9872838B2 (en) Raloxifene sprinkle composition
US20050171119A1 (en) Pharmaceutical formulations with modified release
Helin-Tanninen et al. Oral solids
van Basten Oral Solids
WO2015189807A1 (en) Bi-layer tablet formulations of cyclophosphamide and capecitabine and highly fractionated metronomic administration thereof
Oliveira Preparation and Characterization of a Time-Dependent Drug Delivery System by Tablet Press-Coating
AU2017233134A1 (en) Dutasteride- and tamsulosin-containing hard capsule complex and preparation method therefor
Hadi Development and evaluation of mini-tablets-filed-capsule system for chronotherapeutic delivery of montelukast
TW201536292A (zh) 癌症治療方法
KR20160033201A (ko) 오심 및 구토의 관리용 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination